The Patient with Postprandial Right Upper Quadrant Abdominal Pain


  1. D'Hondt M, et al. Carcinoma of the gallbladder: Patterns of presentation, prognostic factors and survival rate. An 11-year single centre experience. Eur J Surg Oncol. 2013;39(6):548-553.
  2. Kiran RP, et al. Incidence pattern and survival for gallbladder cancer over three decades—an analysis of 10301 patients. Ann Surg Oncol. 2007;14:827-832.
  3. Aldridge MC, Bismuth H. Gallbladder cancer: the polyp-cancer sequence. Br J Surg. 1990;77(4):363-364.
  4. Foster JM, et al. Gallbladder cancer: Defining the indications for primary radical resection and radical re-resection. Ann Surg Oncol. 2007;14:833-840.
  5. Shih SP, et al. Gallbladder cancer: The role of laparoscopy and radical resection. Ann Surg. 2007;245:893-901.
  6. Tumors of the gallbladder. Blumgart LH, ed. Surgery of the Liver, Biliary Tract, and Pancreas. 4th ed. Philadelphia, Pa: Saunders Elsevier; 2007:764-781.
  7. Matos AS, et al. Gallbladder polyps: How should they be treated and when? Rev Assoc Med Bras. 2010;56:318-321.
  8. Inui K, et al. Diagnosis of gallbladder tumors. Intern Med. 2011;50:1133-1136.
  9. Kwon W, et al. Clinicopathologic features of polypoid lesions of the gallbladder and risk factors of gallbladder cancer. J Korean Med Sci. 2009;24:481-487.
  10. Andrén-Sandberg A. Diagnosis and Management of Gallbladder Polyps. N Am J Med Sci. 2012;4(5):203-211.
  11. Aldridge MC, et al. Adenomyomatosis of the gallbladder. A premalignant lesion? Surgery. 1991;109(1):107-110.
  12. Misra S, et al. Carcinoma of the gallbladder. Lancet Oncol. 2003;4:167-176.
  13. Kiran RP, et al. Incidence pattern and survival for gallbladder cancer over three decades—an analysis of 10301 patients. Ann Surg Oncol. 2007;14:827-832.
  14. Reddy SK, Clary BM. Surgical management of gallbladder cancer. Surg Oncol Clin N Am. 2009;18(2):307-324.
  15. Valle JW, et al. Gemcitabine with or without cisplatin in patients (pts) with advanced or metastatic biliary tract cancer (ABC): Results of a multicenter, randomized phase III trial (the UK ABC-02 trial). J Clin Oncol. 2009;27(15 suppl):4503.
  16. Dingle BH, et al. The role of gemcitabine in the treatment of cholangiocarcinoma and gallbladder cancer: a systematic review. Can J Gastroenterol. 2005;19(12):711-716.
  17. Cho JY, et al. Capecitabine combined with gemcitabine (CapGem) as first-line treatment in patients with advanced/metastatic biliary tract carcinoma. Cancer. 2005;104(12):2753-2758.
  18. Hepatobiliary cancers. NCCN Clinical Practice Guidelines in Oncology. Available at
  19. Clary B, et al. Hilar cholangiocarcinoma. J Gastrointest Surg. 2004;8(3):298-302.
  20. de Groen PC, et al. Biliary tract cancers. N Engl J Med. 1999;341(18):1368-1378.
  21. Chalasani N, et al. Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study. Hepatology. 2000;31(1):7-11.
  22. Singal AK, et al. Intra-hepatic cholangiocarcinoma--frequency and demographic patterns: thirty-year data from the M.D. Anderson Cancer Center. J Cancer Res Clin Oncol. 2011;137(7):1071-1078.
  23. Ortner MA, et al. Photodynamic therapy of nonresectable cholangiocarcinoma. Gastroenterology. 1998;114(3):536-542.
  24. Ortner ME, et al. Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study. Gastroenterology. 2003;125(5):1355-1363.
  25. Thongprasert S, et al. Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma. Ann Oncol. 2005;16(2):279-281.
  26. Thongprasert S. The role of chemotherapy in cholangiocarcinoma. Ann Oncol. 2005;16 Suppl 2:ii93-96.
  27. Heimbach JK, et al. Transplantation for hilar cholangiocarcinoma. Liver Transpl. 2004;10(10 Suppl 2):S65-68.